BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-1.54%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$632M
AUM Growth
+$632M
(-1.2%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Axon Enterprise
AXON
|
$14.5M |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$8.33M |
Top Sells
| 1 |
Monster Beverage
MNST
|
$1.36M |
Sector Composition
| 1 | Consumer Staples | 43.24% |
| 2 | Healthcare | 41.93% |
| 3 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Monster Beverage
MNST
$60.9B
| $273M | 39.68% | 4,773,708 -23,700 | -0.5% | -$1.36M |
|
2
STAAR Surgical
STAA
$1.36B
| $161M | 23.34% | 10,855,179 | – | – |
|
3
Lineage Cell Therapeutics
LCTX
$267M
| $80.6M | 11.71% | 29,971,561 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $63.8M | 9.26% | 420,000 | – | – |
|
|
5
Axon Enterprise
AXON
$58.7B
| $29.9M | 4.34% | 760,062 +368,970 | +94% | +$14.5M |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $15.9M | 2.31% | 7,564,934 +3,968,254 | +110% | +$8.33M |
|
|
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $7.67M | 1.11% | 5,292,156 | – | – |
|
8
Boeing
BA
$177B
| – | – | 0 | – | – |
|
9
Delta Air Lines
DAL
$40.3B
| – | – | 0 | – | – |
|